Revised SPC: Neupro (rotigotine) transdermal patch – all strengths

Special warnings and precautions for use section of SPC updated to include information on symptoms of dopamine agonist withdrawal syndrome and reference to dopamine dysregulation syndrome, a potential adverse effect of treatment

Source:

electronic Medicines compendium